Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 777-785

  Smedberg, Jason R ^a   Westcott, Marlena M ^a   Ahmed, Maryam ^b   Lyles, Douglas S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b APPALACHIAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; FLAGELLIN; GLYCOPROTEIN P 15095; INFLAMMASOME; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; M PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 5; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE DELETION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PYROPTOSIS; SALMONELLA ENTERICA; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS GENOME; VIRUS VIRULENCE;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; FLAGELLIN; GENETIC VECTORS; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL MATRIX PROTEINS;

EID: 84891689100     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02898-13     Document Type: Article

References (43)

1. Geisbert TW, Feldmann H. 2011. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J. Infect. Dis. 204(Suppl 3):S1075-S1081. http://dx.doi.org/10.1093/infdis/jir349.
2. Schwartz JA, Buonocore L, Suguitan AL, Jr, Silaghi A, Kobasa D, Kobinger G, Feldmann H, Subbarao K, Rose JK. 2010. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. J. Virol. 84:4611-4618. http://dx.doi.org/10.1128/JVI.02637-09.
3. Rollier CS, Reyes-Sandoval A, Cottingham MG, Ewer K, Hill AV. 2011. Viral vectors as vaccine platforms: deployment in sight. Curr. Opin. Immunol. 23:377-382. http://dx.doi.org/10.1016/j.coi.2011.03.006.
4. Kurihara K, Takahara Y, Nomura T, Ishii H, Iwamoto N, Takahashi N, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Moriya C, Matano T. 2012. Immunogenicity of repeated Sendai viral vector vaccination in macaques. Microbes Infect. 14:1169-1176. http://dx.doi.org/10.1016/j.micinf.2012.07.016.
5. Clarke DK, Nasar F, Lee M, Johnson JE, Wright K, Calderon P, Guo M, Natuk R, Cooper D, Hendry RM, Udem SA. 2007. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations. J. Virol. 81:2056-2064. http://dx.doi.org/10.1128/JVI.01911-06.
6. Ahmed M, Puckett S, Arimilli S, Braxton CL, Mizel SB, Lyles DS. 2010. Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin. J. Virol. 84:12093-12098. http://dx.doi.org/10.1128/JVI.00406-10.
7. Arimilli S, Johnson JB, Clark KM, Graff AH, Alexander-Miller MA, Mizel SB, Parks GD. 2008. Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function. J. Virol. 82:10975-10985. http://dx.doi.org/10.1128/JVI.01288-08.
8. Delaney KN, Phipps JP, Johnson JB, Mizel SB. 2010. A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice. Viral Immunol. 23:201-210. http://dx.doi.org/10.1089/vim.2009.0107.
9. Leng J, Stout-Delgado HW, Kavita U, Jacobs A, Tang J, Du W, Tussey L, Goldstein DR. 2011. Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection. Vaccine 29:8147-8155. http://dx.doi.org/10.1016/j.vaccine.2011.08.027.
10. Zhou M, Zhang G, Ren G, Gnanadurai CW, Li Z, Chai Q, Yang Y, Leyson CM, Wu W, Cui M, Fu ZF. 2013. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. PLoS One 8:e63384. http://dx.doi.org/10.1371/journal.pone.0063384.
11. Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y. 2007. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81:8601-8612. http://dx.doi.org/10.1128/JVI.00608-07.
12. Cobleigh MA, Buonocore L, Uprichard SL, Rose JK, Robek MD. 2010. A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose. J. Virol. 84:7513-7522. http://dx.doi.org/10.1128/JVI.00200-10.
13. Schell JB, Rose NF, Bahl K, Diller K, Buonocore L, Hunter M, Marx PA, Gambhira R, Tang H, Montefiori DC, Johnson WE, Rose JK. 2011. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen. J. Virol. 85:5764-5772. http://dx.doi.org/10.1128/JVI.00342-11.
14. Kapadia SU, Rose JK, Lamirande E, Vogel L, Subbarao K, Roberts A. 2005. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology 340:174-182. http://dx.doi.org/10.1016/j.virol.2005.06.016.
15. Roberts A, Reuter JD, Wilson JH, Baldwin S, Rose JK. 2004. Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein. J. Virol. 78:3196-3199. http://dx.doi.org/10.1128/JVI.78.6.3196-3199.2004.
16. Flanagan EB, Zamparo JM, Ball LA, Rodriguez LL, Wertz GW. 2001. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. J. Virol. 75:6107-6114. http://dx.doi.org/10.1128/JVI.75.13.6107-6114.2001.
17. Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 77:4646-4657. http://dx.doi.org/10.1128/JVI.77.8.4646-4657.2003.
18. Braxton CL, Puckett SH, Mizel SB, Lyles DS. 2010. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens. J. Virol. 84:3552-3561. http://dx.doi.org/10.1128/JVI.01572-09.
19. Ahmed M, Marino TR, Puckett S, Kock ND, Lyles DS. 2008. Immune response in the absence of neurovirulence in mice infected with M protein mutant vesicular stomatitis virus. J. Virol. 82:9273-9277. http://dx.doi.org/10.1128/JVI.00915-08.
20. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 101:5598-5603. http://dx.doi.org/10.1073/pnas.0400937101.
21. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010.
22. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243.
23. Bates JT, Uematsu S, Akira S, Mizel SB. 2009. Direct stimulation of tlr5+/+CD11c+ cells is necessary for the adjuvant activity of flagellin. J. Immunol. 182:7539-7547. http://dx.doi.org/10.4049/jimmunol.0804225.
24. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, Liu L, Shao F. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596-600. http://dx.doi.org/10.1038/nature10510.
25. Mizel SB, Bates JT. 2010. Flagellin as an adjuvant: cellular mechanisms and potential. J. Immunol. 185:5677-5682. http://dx.doi.org/10.4049/jimmunol.1002156.
26. Honko AN, Mizel SB. 2005. Effects of flagellin on innate and adaptive immunity. Immunol. Res. 33:83-101. http://dx.doi.org/10.1385/IR:33:1:083.
27. Koizumi Y, Toma C, Higa N, Nohara T, Nakasone N, Suzuki T. 2012. Inflammasome activation via intracellular NLRs triggered by bacterial infection. Cell Microbiol. 14:149-154. http://dx.doi.org/10.1111/j.1462-5822.2011.01707.x.
28. Lamkanfi M, Dixit VM. 2011. Modulation of inflammasome pathways by bacterial and viral pathogens. J. Immunol. 187:597-602. http://dx.doi.org/10.4049/jimmunol.1100229.
29. Aachoui Y, Sagulenko V, Miao EA, Stacey KJ. 2013. Inflammasomemediated pyroptotic and apoptotic cell death, and defense against infection. Curr. Opin. Microbiol. 16:319-326. http://dx.doi.org/10.1016/j.mib.2013.04.004.
30. Lamkanfi M, Dixit VM. 2012. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28:137-161. http://dx.doi.org/10.1146/annurev-cellbio-101011-155745.
31. Lefrancois L, Lyles DS. 1982. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121:157-167.
32. McCreedy BJ, Jr, Lyles DS. 1989. Distribution of M protein and nucleocapsid protein of vesicular stomatitis virus in infected cell plasma membranes. Virus Res. 14:189-205. http://dx.doi.org/10.1016/0168-1702(89)90001-4.
33. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702. http://dx.doi.org/10.1084/jem.176.6.1693.
34. Merad M, Sathe P, Helft J, Miller J, Mortha A. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31:563-604. http://dx.doi.org/10.1146/annurev-immunol-020711-074950.
35. Ahmed M, Brzoza KL, Hiltbold EM. 2006. Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells. J. Virol. 80:2194-2205. http://dx.doi.org/10.1128/JVI.80.5.2194-2205.2006.
36. Westcott MM, Ahmed M, Smedberg JR, Rajani KR, Hiltbold EM, Lyles DS. 2013. Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein. J. Virol. 87:11730-11740. http://dx.doi.org/10.1128/JVI.00680-13.
37. Rajan JV, Rodriguez D, Miao EA, Aderem A. 2011. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J. Virol. 85:4167-4172. http://dx.doi.org/10.1128/JVI.01687-10.
38. Kopecky SA, Willingham MC, Lyles DS. 2001. Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J. Virol. 75:12169-12181. http://dx.doi.org/10.1128/JVI.75.24.12169-12181.2001.
39. Gaddy DF, Lyles DS. 2007. Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx. J. Virol. 81:2792-2804. http://dx.doi.org/10.1128/JVI.01760-06.
40. Gaddy DF, Lyles DS. 2005. Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways. J. Virol. 79:4170-4179. http://dx.doi.org/10.1128/JVI.79.7.4170-4179.2005.
41. Shortman K, Heath WR. 2010. The CD8+ dendritic cell subset. Immunol. Rev. 234:18-31. http://dx.doi.org/10.1111/j.0105-2896.2009.00870.x.
42. Joffre OP, Segura E, Savina A, Amigorena S. 2012. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12:557-569. http://dx.doi.org/10.1038/nri3254.
43. Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L, Kavita U, Stanberry L, Shaw A. 2011. Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 29:5145-5152. http://dx.doi.org/10.1016/j.vaccine.2011.05.041.